Denmark
Macure is a specialty pharmaceutical company that positions itself as a notable player in both the Nordic and broader European markets, driven by its slogan: "Nordic Quality. European Expertise. International Reach." Founded in 2013 and headquartered in Denmark, this privately owned entity has expanded its commercial reach to over 25 countries, establishing a robust presence across Western Europe.
Specializing in niche pharmaceuticals that fulfill unmet medical needs, Macure adopts a flexible approach to efficiently deliver high-quality treatments. The company's core strategy involves forming vital partnerships to further its growth, focusing on in-licensing specialty generics for the EU and UK, acquiring rights to established treatments, and collaborating internationally.
Despite the absence of recent investments, Macure boasts a solid history of acquisitions from major pharmaceutical companies in both Europe and the US. This underscores its commitment to expanding its portfolio and reinforcing its market position, making it an attractive consideration for potential investors.
